Over 10,000 filings
Page 3 of 100
6-K
vhi6ur
19 Apr 24
Current report (foreign)
8:31am
6-K
ztz3bhnu dejr9
19 Apr 24
Current report (foreign)
8:31am
6-K
i2w86
19 Apr 24
Batch Filing
8:23am
6-K
6e8ah1w62x5k
19 Apr 24
Preliminary Results for the Year Ended 31 December 2023
8:19am
6-K
lemdpvlrab jjd85x
19 Apr 24
Transaction In Own Shares
8:13am
6-K
8kzrp9i0cesp43y
19 Apr 24
Current report (foreign)
8:05am
6-K
cj0te3iqk kzjxsu
19 Apr 24
Report of Foreign Private Issuer
8:04am
6-K
nc36m7 c56vrx2paoqlq
19 Apr 24
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
8:03am
6-K
ww8hhqsvza5tav9f3lm
19 Apr 24
Current report (foreign)
8:03am
6-K
k6735ly0
19 Apr 24
Report of Foreign Private Issuer
8:00am
6-K
gj1 kehi1vgz03
19 Apr 24
Current report (foreign)
7:49am
6-K
6actnx
19 Apr 24
Current report (foreign)
7:48am
6-K
7ay0ktpgc7s
19 Apr 24
Current report (foreign)
7:22am
6-K
nfd5tn vr5rx2
19 Apr 24
Current report (foreign)
7:20am
6-K
rsjs7uzuzt
19 Apr 24
ProQR Achieves Successful Defense of New Challenge to its Axiomerâ„¢ IP Portfolio
7:06am
6-K
9fxr8
19 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
sw18ym ke
19 Apr 24
Baozun Strengthens Leadership Team
6:44am
6-K
es89jd15t
19 Apr 24
Current report (foreign)
6:37am
6-K
j8mt9sfoytnmgz
19 Apr 24
First Quarter Report for Period Ended 31Â March 2024
6:30am
6-K
awje 66v1i19krtc
19 Apr 24
Current report (foreign)
6:12am